Cardiovascular disease (CVD) is known as the number one cause of death worldwide. It is associated with huge health care costs and loss of productivity in the population. Poor diet is an important risk factor in CVD. Diet rich in polyunsaturated fatty acids, such as virgin coconut oil (VCO), has been associated with a reduced risk of CVD. This systematic review focused on studies that reported the association between VCO and the biochemical measurements associated with CVD. These studies conclude that VCO shows promising effects in improving the biochemical derangements associated with CVD, thus lowering the CVD risk. However, most of these studies were performed in animals with very limited data from human. Future investigations are needed to examine the health benefits of VCO in human intervention studies.
Cardiovascular disease (CVD), one of the major non-communicable diseases, is known as the number one cause of death worldwide [1] . In 2012, approximately 17.5 million people died from CVD, which accounted for 31% of all worldwide deaths [1] . The economic burden of CVD has been estimated to be more than USD$400 billion in terms of health care spending and loss of productivity [2] . One important risk factor for CVD is poor diet [3] . Although expensive therapeutic procedures can be used to treat CVD, it would be better to emphasize the importance of diet modification to prevent and reduce CVD risk which will have an impact on reducing health care cost and resources [2] , particularly in the middle and lower income countries with limited health care funding [4a] . Therefore, improving diet is one of the critical strategies for the American Heart Association to prevent CVD in the general population [4b]. High intakes of total fat and saturated fatty acid (SFA) are associated with a higher risk of CVD [4c,5,6a], while a higher consumption of polyunsaturated fatty acid can decrease the risk of CVD [6b]. Foods that are rich in polyunsaturated fatty acids include virgin coconut oil.
Virgin coconut oil (VCO) is the oil extracted from fresh mature coconut kernels at low temperature and without undergoing refining processes [7a] . The wet extraction process of VCO helps to retain the biological activities of the beneficial components in VCO compared with the dry method used to extract coconut oil [7b]. Coconut oil is extracted by drying and chemical refining, which might destroy some of the beneficial components [8] . The consumption of VCO is more popular and considered superior to coconut oil because of its better beneficial qualities [8] .
Chemical properties of VCO:
VCO is colorless with a slightly detectable acid aroma and coconut scent [7a,9a] . VCO is composed predominantly of medium chain fatty acids. Although the major fatty acid found in VCO is lauric acid (~50%) [9a,b] , the growing conditions and extraction method can affect the concentration of lauric acid in VCO [10] . Furthermore, VCO has a higher concentration of total polyphenols (84 mg/100 g) and vitamin E (33 μg/100 g) [11a,b] .
Search strategy:
In this review, we performed a search in PubMed and Ovid Medline using various combination terms as follows:
virgin coconut oil, coconut oil, clinical trials, cardiovascular, antioxidant, blood pressure, lipid, animals and humans. The search was limited to studies published in English from inception to February 2016. Additional publications from reference lists of the retrieved studies were also located. After screening through the titles, abstracts and keywords of the studies which met the eligibility for this review, the relevant studies were selected and included.
Antioxidant activity: VCO improves antioxidant activity [12, 13] . In an in vivo study, mice fed with VCO had a lower peroxidation and an increase in concentration of superoxide dismutase (SOD) enzyme [14a] . Nevin and Rajamohan [12] also found a higher activity of catalase (CAT), SOD, glutathione peroxidase (GPx) and glutathione reductase enzymes (GR) in rats fed with VCO. Similarly, another study by Arunima and Rajamohan [11b] reported that VCO-fed rats had a higher activity of catalase, SOD, GPx and GR than rats fed with coconut oil, olive oil and sunflower oil (P<0.05). For example, VCO increased the activity of catalase by 20% in kidney, 26% in liver and 72% in heart compared with coconut oil (P<0.05). An increase in these antioxidant enzymes is associated with an improvement in antioxidant status because these enzymes protect against free radical mediated damage and prevent lipid peroxidation [14b]. It is suggested that the increased concentration of antioxidant enzymes is due to a higher content of polyphenols and vitamin E in VCO.
Lipid profile:
In vivo studies have shown that VCO improves the lipid profile by decreasing the concentrations of total cholesterol, triglycerides and low density lipoprotein cholesterol (LDL) [7b,11a]. In addition, VCO increases high density lipoprotein cholesterol (HDL) [11a] . A study by Nevin and Rajamohan [11a] reported that VCO-fed rats had a lower LDL and an increased HDL compared with the controls and rats fed with coconut oil. In addition, Arunima and Rajamohan [11b] reported that VCO-fed rats had a higher activity of paraoxonase-1 enzyme (PON1) than rats fed with coconut oil, olive oil and sunflower oil (P<0.05). A higher activity of PON1 is associated with an increased concentration of high density lipoprotein cholesterol (HDL) and apolipoprotein A-I (apoA-I), which are protective against cardiovascular diseases [14c,d]. Ma & Lee Blood pressure: Hypertension is a major risk factor for cardiovascular diseases. VCO has been shown to have a beneficial effect on blood pressure. Nurul-Iman et al. [15] reported that rats fed with repeatedly heated palm oil and VCO had a lower pressure and a higher concentration of plasma nitric oxide than rats fed with only repeatedly heated palm oil.
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Blood sugar: VCO may have an effect on the control of blood sugar because VCO is rich in medium chain fatty acids. Garfinkel et al. [16] reported that in an isolated perfused islet model, lauric acid and capric acid were among the fatty acids that gave a significant stimulation over basal insulin secretion. It is possible that the enhanced effect of these medium chain fatty acids on insulin is due to rapid oxidation of these fatty acids [17] .
Obesity: A four-week human intervention study by Liau et al. [18] reported that supplementation with VCO significantly reduced the waist circumference of obese adults at the end of the study. It is possible that this was due to significant reduction of abdominal body fat from the high concentration of medium chain fatty acids in the VCO [19] .
VCO is associated with an improvement in antioxidant activity, lipid profile, blood pressure, blood sugar and abdominal body fat. This is because VCO is rich in polyunsaturated acids which are beneficial to cardiovascular health. However, the majority of studies that have investigated the beneficial effects of VCO on health have been with animals. Limited studies have been conducted in humans. It is unknown if the beneficial effects of VCO found in animal studies can be extended to humans. Future studies should investigate the efficacy and safety of long-term consumption of VCO in human populations.
